Europe Malaria Treatment Market to 2030 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Europe Malaria Treatment Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Europe Malaria Treatment Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Increasing Prevalence of Malaria
5.1.2 Rising Initiatives to Raise Awareness about Malaria

5.2 Market Opportunities

5.2.1 Growing Strategic Initiatives by Market Players

5.3 Future Trends

5.3.1 Extending Pipeline of New Drugs and Vaccines

5.4 Impact of Drivers and Restraints

6. Europe Malaria Treatment Market Regional Analysis

6.1 Europe Malaria Treatment Market Overview

6.2 Europe Malaria Treatment Market Revenue 2020-2030 (US$ Million)

6.3 Europe Malaria Treatment Market Forecast Analysis

7. Europe Malaria Treatment Market Analysis – by Treatment

7.1 Generic Drugs

7.1.1 Overview
7.1.2 Generic Drugs: Europe Malaria Treatment Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Originators

7.2.1 Overview
7.2.2 Originators: Europe Malaria Treatment Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Vaccines

7.3.1 Overview
7.3.2 Vaccines: Europe Malaria Treatment Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Malaria Treatment Market Analysis – by Route of Administration

8.1 Oral

8.1.1 Overview
8.1.2 Oral: Europe Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)

8.2 Parenteral

8.2.1 Overview
8.2.2 Parenteral: Europe Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)

9. Europe Malaria Treatment Market Analysis – by Distribution Channel

9.1 Direct Tender

9.1.1 Overview
9.1.2 Parenteral: Europe Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)

9.2 Hospital Pharmacies

9.2.1 Overview
9.2.2 Parenteral: Europe Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)

9.3 Retail Pharmacies

9.3.1 Overview
9.3.2 Parenteral: Europe Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)

9.4 Online Pharmacies

9.4.1 Overview
9.4.2 Parenteral: Europe Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)

10. Europe Malaria Treatment Market – Europe Analysis

10.1 Europe

10.1.1 Europe Malaria Treatment Market Breakdown, by Key Country, 2023 and 2030 (%)
10.1.1.1 Europe Malaria Treatment Market – Revenue and Forecast Analysis – by Country
10.1.1.1 UK: Europe Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.1 UK: Europe Malaria Treatment Market Breakdown, by Treatment
10.1.1.1.2 UK: Europe Malaria Treatment Market Breakdown, by Route of Administration
10.1.1.1.3 UK: Europe Malaria Treatment Market Breakdown, by Distribution Channel

10.1.1.2 Germany: Europe Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1 Germany: Europe Malaria Treatment Market Breakdown, by Treatment
10.1.1.2.2 Germany: Europe Malaria Treatment Market Breakdown, by Route of Administration
10.1.1.2.3 Germany: Europe Malaria Treatment Market Breakdown, by Distribution Channel

10.1.1.3 France: Europe Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 France: Europe Malaria Treatment Market Breakdown, by Treatment
10.1.1.3.2 France: Europe Malaria Treatment Market Breakdown, by Route of Administration
10.1.1.3.3 France: Europe Malaria Treatment Market Breakdown, by Distribution Channel

10.1.1.4 Russia: Europe Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.1 Russia: Europe Malaria Treatment Market Breakdown, by Treatment
10.1.1.4.2 Russia: Europe Malaria Treatment Market Breakdown, by Route of Administration
10.1.1.4.3 Russia: Europe Malaria Treatment Market Breakdown, by Distribution Channel

10.1.1.5 Italy: Europe Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.5.1 Italy: Europe Malaria Treatment Market Breakdown, by Treatment
10.1.1.5.2 Italy: Europe Malaria Treatment Market Breakdown, by Route of Administration
10.1.1.5.3 Italy: Europe Malaria Treatment Market Breakdown, by Distribution Channel

10.1.1.6 Rest of Europe: Europe Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.6.1 Rest of Europe: Europe Malaria Treatment Market Breakdown, by Treatment
10.1.1.6.2 Rest of Europe: Europe Malaria Treatment Market Breakdown, by Route of Administration
10.1.1.6.3 Rest of Europe: Europe Malaria Treatment Market Breakdown, by Distribution Channel

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Europe Malaria Treatment Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Cipla Ltd

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Sun Pharmaceutical Industries Ltd

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Sanofi SA

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 GSK Plc

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Novartis AG

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Pfizer Inc

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Lupin Ltd

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - E Market

1. Cipla Ltd
2. Sun Pharmaceutical Industries Ltd
3. Sanofi SA
4. GSK Plc
5. Novartis AG
6. Pfizer Inc
7. Lupin Ltd